60 DEGREES PHARMACEUTICALS, INC. Capital Expenditures
60 DEGREES PHARMACEUTICALS, INC. (SXTP) reported Capital Expenditures of $30.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-14
- 60 DEGREES PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- 60 DEGREES PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $30.00K, a 1020.24% increase year-over-year.
- 60 DEGREES PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $79.88K.
- 60 DEGREES PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $10.00K, a 27.40% decline year-over-year.
- 60 DEGREES PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $139.88K, a 34.80% increase from fiscal 2024.
- 60 DEGREES PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $103.77K, a 80.09% increase from fiscal 2023.
- 60 DEGREES PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $57.62K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $30.00K 10-Q · filed 2026-08-14 | $109.88K derived: sum of 3 quarters · filed 2026-08-14 | $119.88K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $30.00K 10-Q · filed 2026-05-15 | $109.88K derived: sum of 2 quarters · filed 2026-05-15 | $119.88K derived: sum of 3 quarters · filed 2026-05-15 | $167.20K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $79.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $89.88K derived: sum of 2 quarters · filed 2026-03-30 | $137.20K derived: sum of 3 quarters · filed 2026-08-14 | $139.88K 10-K · filed 2026-03-30 |
| 2025-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $57.32K derived: sum of 2 quarters · filed 2026-08-14 | $60.00K 10-Q · filed 2025-11-13 | $60.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $47.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $50.00K 10-Q · filed 2026-08-14 | $50.00K derived: sum of 3 quarters · filed 2026-08-14 | $63.77K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $2.68K 10-Q · filed 2026-05-15 | $2.68K derived: sum of 2 quarters · filed 2026-05-15 | $16.45K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $13.77K derived: sum of 2 quarters · filed 2026-03-30 | $103.77K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $13.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $103.77K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $90.00K 10-Q · filed 2025-08-13 | |||
| 2023-12-31 | $55.80K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $57.62K 10-K · filed 2025-03-27 | ||
| 2023-09-30 | $1.82K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |